Get the Stockscreener App
266.78
0.05%
-0.14
After Hours:
266.78
Insulet Corporation stock is traded at $266.78, with a volume of 192.76K.
It is down -0.05% in the last 24 hours and up +14.81% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
See More
Previous Close:
$266.92
Open:
$266.36
24h Volume:
192.76K
Relative Volume:
0.32
Market Cap:
$18.71B
Revenue:
$1.98B
Net Income/Loss:
$420.90M
P/E Ratio:
156.01
EPS:
1.71
Net Cash Flow:
$218.20M
1W Performance:
+1.46%
1M Performance:
+14.81%
6M Performance:
+54.88%
1Y Performance:
+41.21%
1-Day Range:
$264.69
$267.90
1-Week Range:
$263.63
$272.56
52-Week Range:
$160.19
$279.40
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
266.78 | 18.71B | 1.98B | 420.90M | 218.20M | 5.84 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Here's Why Insulet (PODD) is a Strong Growth Stock - MSN
Insulet Co. (NASDAQ:PODD) Holdings Lifted by Bank of Montreal Can - MarketBeat
Dai ichi Life Insurance Company Ltd Sells 10,200 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink? - MSN
If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now - MSN
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US - MSN
FY2028 EPS Estimates for Insulet Lifted by Leerink Partnrs - MarketBeat
Insulet Co. (NASDAQ:PODD) Stake Boosted by Algert Global LLC - MarketBeat
Are Wall Street Analysts Predicting Insulet Stock Will Climb Or Sink? - Barchart
Leerink Partnrs Has Negative Outlook for Insulet Q4 Earnings - MarketBeat
Fisher Asset Management LLC Grows Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Charles Schwab Investment Management Inc. Has $148.09 Million Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Wearable Patch Market to Expand at a High 7.9% CAGR through 2031 | SkyQuest Technology - Benzinga
Trend Tracker for (PODD) - Stock Traders Daily
Westfield Capital Management Co. LP Acquires 163,388 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Primecap Management Co. CA Sells 27,580 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
9,542 Shares in Insulet Co. (NASDAQ:PODD) Purchased by B. Metzler seel. Sohn & Co. Holding AG - MarketBeat
Banque Cantonale Vaudoise Decreases Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Jennison Associates LLC Has $30.25 Million Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Natixis Advisors LLC - MarketBeat
PODDInsulet Corporation Latest Stock News & Market Updates - StockTitan
Brown Capital Management LLC Sells 11,147 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster - Yahoo Finance
Insulet: Superb Business Growth, Starting Valuations Outsized Risk (NASDAQ:PODD) - Seeking Alpha
Segall Bryant & Hamill LLC Boosts Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth - Insider Monkey
Insulet Corporation: Significant Opportunities, Significant ThreatsI'm On The Sidelines - Seeking Alpha
Indexes Show More Strength, Pare Losses: Blue Owl, Chewy, Insulet In FocusVideoIBD - Investor's Business Daily
Insulet To Present At Wolfe Research Healthcare Conference; Webcast At 12:00 PM ET - Nasdaq
Goldman Sachs: Insulet Corporation (PODD) Is A Top Growth Investor Stock - Insider Monkey
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More - MSN
Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S. - Business Wire
Insulet's Omnipod 5 Expands Leadership with FreeStyle Libre 2 Plus Integration | PODD Stock News - StockTitan
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - MSN
LMR Partners LLP Purchases New Shares in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Insulet Corp - Cyber Magazine
Mizuho Securities USA LLC Boosts Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals - Yahoo Finance
GSA Capital Partners LLP Invests $1.02 Million in Insulet Co. (NASDAQ:PODD) - MarketBeat
Commit To Buy Insulet At $260, Earn 15.4% Annualized Using Options - Nasdaq
Insulet to Present at Major Healthcare Conferences, Showcasing Omnipod 5 Innovation | PODD Stock News - StockTitan
Insulet to Present at Upcoming Investor Conferences - Business Wire
William Blair Has Optimistic Outlook of Insulet Q3 Earnings - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Principal Financial Group Inc. - MarketBeat
Insulet corp director Luciana Borio sells $139,598 in stock - Investing.com
Insider Sale: Director Luciana Borio Sells Shares of Insulet Cor - GuruFocus.com
Insulet corp director Luciana Borio sells $139,598 in stock By Investing.com - Investing.com UK
William Blair Issues Optimistic Outlook for Insulet Earnings - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):